Clinical Trials Logo

Hyperglycemia clinical trials

View clinical trials related to Hyperglycemia.

Filter by:

NCT ID: NCT03651713 Completed - Hyperglycemia Clinical Trials

Hyperglycemia, Exercise, and Endothelial Function

Start date: October 15, 2018
Phase: N/A
Study type: Interventional

The main purpose of this study is to determine if exercise preserves vascular function during hyperglycemia. All subjects will consume a sugary beverage three times daily for seven days. Subjects will be randomly assigned to either the glucose with (GLU+EX) or without (GLU) structured exercise group.

NCT ID: NCT03646370 Completed - Clinical trials for Cardiovascular Diseases

Assessing Virologic Success and Metabolic Changes in Patients Switching From a TDF to TAF Containing Antiretroviral Therapy Regimen

Start date: July 25, 2018
Phase:
Study type: Observational

Switching patients with HIV infection from tenofovir disoproxil fumarate (TDF) to a tenofovir alafenamide (TAF) based drug regimen can provide many safety benefits including preserving bone mineral density and kidney function. This study will examine metabolic changes that patients may encounter due to the switch in medication regimens and the maintenance of viral suppression.

NCT ID: NCT03643094 Completed - Hyperglycemia Clinical Trials

Golden Black Seed: Support of Metabolic Health and General Wellness.

Start date: March 14, 2018
Phase: N/A
Study type: Interventional

To document effects of consuming Golden Black Seed (brand: New Chapter Inc.) on metabolic health and wellness in human subjects. Golden Black Seed contains extracts from the turmeric root (Curcuma longa) and black cumin seeds (Nigella sativa). Both botanicals have been used traditionally in Asian cooking, and also in herbal medicine for reducing inflammation.

NCT ID: NCT03552315 Completed - Clinical trials for Type 2 Diabetes Mellitus

Effects of a Carbonated Water Enriched With Amino Acids and Chromium Picolinate (Good Idea®) on Glucose Homeostasis.

Start date: April 24, 2018
Phase: N/A
Study type: Interventional

It has previously been shown in healthy subjects, that a carbonated water containing a mix of amino acids and chromium picolinate can decrease postprandial blood glucose. Based on these findings, a flavored sparkling water product called Good Idea® with a proprietary blend of five amino acids and chromium picolinate has been developed. This product, along with an identical placebo, are included in this study to evaluate the effects on postprandial blood glucose in healthy, overweight adults when consumed with a standardized, high glycemic test meal. The study will be conducted in a cross-over design, double-blinded and placebo controlled, including 45 participants. The primary endpoint of the study is the incremental area under the curve (iAUC) for capillary blood glucose within 180 minutes after ingestion of the meal.

NCT ID: NCT03544411 Completed - Clinical trials for Diabetes Mellitus, Type 2

Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM

Start date: July 2, 2018
Phase: Phase 1
Study type: Interventional

This study determines the effect of olive oil and bran oil on antioxidant levels, and glycemic control in patients with type 2 diabetes mellitus (DM) Intervention: Patient type 2 DM will receive olive oil and bran oil with cross over study

NCT ID: NCT03529344 Completed - Aging Clinical Trials

A Study on the Effects on Glucose Regulation, Inflammation and Serum Lipids After Fish Protein Supplementation in Elderly (GRIPE)

GRIPE
Start date: August 2016
Phase: N/A
Study type: Interventional

The elderly population have and increased risk of loss of both muscle mass and function and is therefore recommended a higher protein intake than the healthy adult population. These age-related changes in muscle function may be explained by chronic low-grade inflammation and insulin resistance. Despite the recommendation of a higher protein intake, little is known about how different protein sources may affect the metabolic health in this population. Analysis of amino acid composition show that fish can be a good protein source for humans. Many fish species are today used as feed ingredients, rather than a protein source for humans. A few studies conducted in humans and rats show that proteins from fish may improve glucose tolerance, reduce inflammation and improve lipid metabolism, indicating that proteins from fish may not only serve as a valuable nutrient but could also hold specific health promoting properties. The present study will investigate the effects of a protein hydrolysate from blue whiting, a fish species normally used to produce fish meal for aquaculture industry, on glucose homeostasis, inflammation and serum lipids in elderly nursing home residents.

NCT ID: NCT03528031 Completed - Diabetes Clinical Trials

Habitual Diet and Avocado Trial

HAT
Start date: June 19, 2018
Phase: N/A
Study type: Interventional

The Habitual Diet and Avocado Trial will evaluate the effects of providing one avocado per day for recommended consumption over a 6 month period in a cohort of approximately 1000 free-living participants with increased waist circumference in comparison with a control group that will maintain their habitual diets. Participants will be recruited and screened at 4 clinics in 4 locations: Pennsylvania State University; Loma Linda University; UCLA, and Tufts University (250 per site).

NCT ID: NCT03522896 Completed - Clinical trials for Effect of Food on Postprandial Hyperglycemia

Effect of Orange Juice on Glycemic Response

Start date: September 30, 2017
Phase: N/A
Study type: Interventional

Orange juice naturally contains high concentrations of hesperidin, which affects glucose absorption in in vitro experiments. This study is to test if hesperidin and other components of orange juice (not other sugars or organic acids) affect the post-prandial blood glucose concentration derived from sugars already present in the orange juice.

NCT ID: NCT03520569 Completed - Insulin Sensitivity Clinical Trials

Effect of Hyperglycemia on Microvascular Perfusion in Healthy Adults

EJB050
Start date: February 4, 2019
Phase: Early Phase 1
Study type: Interventional

The investigators are studying the effects of Hyperglycemia on vascular function and insulin sensitivity on healthy adults

NCT ID: NCT03507829 Completed - Hyperglycemia Clinical Trials

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

ITP-NODAT
Start date: November 21, 2012
Phase: Phase 3
Study type: Interventional

This study aims to assess the effects of early basal insulin therapy in previously non-diabetic de novo kidney transplant patients in reducing the incidence of new onset diabetes in particular and abnormal glucose metabolism in general during subsequent follow-up.The ITP NODAT study should be seen in connection with the Vienna SAPT-NODAT study (clinicaltrials.gov record number: NCT01680185), as for the final analysis, the data yielded from the three arms in those two studies will be used for an pooled analysis.